Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft-versus-host Disease Prevention”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00563589
What this trial is testing

Mycophenolate Mofetil for the Prophylaxis of Graft-versus-host Disease in High Risk Allogeneic Stem Cell Transplantation

Who this might be right for
Graft vs Host DiseaseHematopoietic Stem Cell Transplantation
Hospital Authority, Hong Kong 30
Large-scale testing (Phase 3)Study completedNCT00755040
What this trial is testing

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Vanderbilt-Ingram Cancer Center 164
Testing effectiveness (Phase 2)Active Not RecruitingNCT04202835
What this trial is testing

ATG Plus PTCy vs ATG for CGVHD Prophylaxis

Who this might be right for
Acute LeukemiaMyelodysplasiaChronic Graft-versus-host-disease
McMaster University 80
Testing effectiveness (Phase 2)Temporarily pausedNCT06680661
What this trial is testing

ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphatic LeukemiaChronic Myelogenous Leukemia+5 more
Leland Metheny 20
Not applicableEnded earlyNCT00912561
What this trial is testing

Effects of Intense Aerobic Exercise on the Cerebrovascular Reserve Capacity in Patients With Hemodynamically Relevant Intra- and Extracranial Stenoses

Who this might be right for
Stenosis
Gerhard Jan Jungehuelsing 50
Testing effectiveness (Phase 2)UnknownNCT00377468
What this trial is testing

Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study)

Who this might be right for
Complex Regional Pain SyndromesCRPS
Ludwig-Maximilians - University of Munich 100
Testing effectiveness (Phase 2)Study completedNCT01860170
What this trial is testing

Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis

Who this might be right for
Hematological Malignancy
Corewell Health West 28
Testing effectiveness (Phase 2)Study completedNCT02663622
What this trial is testing

Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)

Who this might be right for
Graft Versus Host DiseaseHematopoietic Stem Cell TransplantationLeukemia
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 44
Large-scale testing (Phase 3)UnknownNCT00934557
What this trial is testing

Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation

Who this might be right for
Paediatric Patients Affected by Haematological Malignancies and Eligible to Undergo HSCT From an Unrelated Volunteer
Fondazione IRCCS Policlinico San Matteo di Pavia 42
Testing effectiveness (Phase 2)Study completedNCT02799147
What this trial is testing

GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia

Who this might be right for
Leukemia, Acute LymphoblasticAcute Myeloid LeukemiaMixed-Lineage Acute Leukemias
St. Petersburg State Pavlov Medical University 27
Large-scale testing (Phase 3)Study completedNCT00655343
What this trial is testing

Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)

Who this might be right for
Graft vs Host Disease
Neovii Biotech 202
Early research (Phase 1)Study completedNCT03755414
What this trial is testing

Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndromes+2 more
Washington University School of Medicine 55
Large-scale testing (Phase 3)Ended earlyNCT04095858
What this trial is testing

Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)

Who this might be right for
Hematopoietic Stem Cell TransplantationAcute Graft Versus Host DiseaseAcute Myeloid Leukemia+2 more
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 11
Large-scale testing (Phase 3)UnknownNCT03631563
What this trial is testing

ATG-F VS ATG for the Prevention of GVHD

Who this might be right for
GVHD in the Setting of Haplo-HSCT
Fujian Medical University 120
Early research (Phase 1)Study completedNCT04131738
What this trial is testing

Baricitinib for the Prophylaxis of Graft-Versus-Host Disease After Peripheral Blood Hematopoietic Cell Transplantation

Who this might be right for
Graft-versus-host-diseaseGraft Vs Host Disease
Washington University School of Medicine 26
Testing effectiveness (Phase 2)WithdrawnNCT07349771
What this trial is testing

Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial

Who this might be right for
Hematopoietic and Lymphatic System Neoplasm
Mayo Clinic
Early research (Phase 1)Study completedNCT03605927
What this trial is testing

CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease

Who this might be right for
Graft-versus-host-diseaseGVHDGVHD, Acute
H. Lee Moffitt Cancer Center and Research Institute 45
Testing effectiveness (Phase 2)Ended earlyNCT00506948
What this trial is testing

Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)

Who this might be right for
Hematological MalignanciesMyelodysplastic SyndromeLeukemia+1 more
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT00089037
What this trial is testing

Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT06348602
What this trial is testing

Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCT

Who this might be right for
Ocular Graft-versus-host Disease
Hospital Universitario Dr. Jose E. Gonzalez 60
Next Page